Gabapentin

Product NDC
59063-127
11-digit product format
590630127
Labeler code
59063
Product ID
59063-127_ce4a0985-fac9-4688-9a48-0f2943bf6434
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
gabapentin
Dosage form
SOLUTION
Route
ORAL
Labeler
Kiel Laboratories, Inc.
Application
ANDA076403
Marketing category
ANDA
Marketing start
2012-05-01
Marketing end
0000-00-00
Substance
GABAPENTIN
Active strength
250 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59063-127-472019-11-13C16284748780-197449f38-ba2f-f6ea-e053-dbdaa90aa703Gabapentin Oral Solution 250 mg / 5 mL R X ONLY

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59063-127-47Gabapentin470 mL in 1 BOTTLESOLUTION4701

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GABAPENTINACTIVE INGREDIENT6CW7F3G59XGABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1
GABAPENTINACTIVE MOIETY6CW7F3G59XGABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXGABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBGABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IGABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RGABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1
XYLITOLINACTIVE INGREDIENTVCQ006KQ1EGABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59063-127GABAPENTIN SOLUTION [KIEL LABORATORIES, INC.]1Legacy NDC, 1 package rows20120518_ce4a0985-fac9-4688-9a48-0f2943bf6434.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
283523gabapentin 250 MG in 5 mL Oral SolutionPSNce4a0985-fac9-4688-9a48-0f2943bf64341
283523gabapentin 50 MG/ML Oral SolutionSCDce4a0985-fac9-4688-9a48-0f2943bf64341
283523gabapentin 250 MG per 5 ML Oral SolutionSYce4a0985-fac9-4688-9a48-0f2943bf64341
283523gabapentin 300 MG per 6 ML Oral SolutionSYce4a0985-fac9-4688-9a48-0f2943bf64341
283523gabapentin 500 MG per 10 ML Oral SolutionSYce4a0985-fac9-4688-9a48-0f2943bf64341

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
59063-127-4759063012747470 mL in 1 BOTTLE470 mlHistorical